Pharmaceuticals

Researchers analyzing recent drug spending in the U.S. say that high-priced drugs for rare diseases aren't having a widespread or significant effect on overall health care spending.

Four years after user fees were imposed to speed up the review of generic drug applications by the Food and Drug Administration, more than 4,000 generics remain in limbo.

Researchers have failed repeatedly in their efforts to slow or halt Alzheimer's disease. But there are hints that an experimental drug can do what previous medicines could not.

Mylan's move comes amid pressure from consumers and Congress to lower the allergy drug's price. In less than 10 years, the price has risen from about $100 to more than $600 for an injector two-pack.

Hundreds of pharmaceutical and medical device firms have paid doctors for their services even after the doctors were disciplined for serious misconduct by state medical boards, an analysis finds.

Researchers found that in states with medical marijuana laws on the books, the number of prescriptions dropped for drugs to treat anxiety, depression, nausea, pain, seizures and sleep disorders.

Researchers say the time doctors spend with drug company representatives when they are dropping off meals is probably more important than the food in influencing prescription choices.

A federal judge approved prosecutors' motion to end a trial of FedEx in San Francisco, but didn't specify a reason. A grand jury indicted the shipping company in 2014. The trial started Monday.

Most antibiotics can't tell the difference between good and bad bacteria. That means medicines can kill helpful bacteria in your gut while they're obliterating the ones making you sick.

A refrigerator-sized machine could someday make lifesaving drugs on site when outbreaks occur or where medicine is in short supply, like on the battlefield.

One man died and five others were injured in a clinical trial in France this year. Trials like those depend on healthy people willing to take experimental medications in return for cash.

In January, one man died and four others sustained brain injuries in the early clinical test of an experimental pain drug. Independent scientists reviewed the study to learn what went wrong.